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Sunday, February 21, 2010 135acontinuous application of depolarization step to 0 mV from HP 80 mV at
1/min. We found that APO inhibited ICa,L in a dose-dependent manner between
0.1 and 10 mM decreasing its amplitude to ~20% of control. APO also accel-
erated ICa,L decay during depolarization. Surprisingly, washout of the high
concentration of APO caused rapid recovery of ICa,L. It could even produce
a rebound increase of ICa,L with its peak at ~3 min in BCASM. We performed
fluorometric analysis of APO-induced change of cellular ROS by loading cells
with 5-(and-6)-chloromethyl-20,70-dichlorodihydrofluorescein diacetate (CM-
H2DCFDA). Oxidation of CM-H2DCF to CM-DCF by ROS induces an increase
of fluorescence. APOmarkedly inhibited the fluorescence increase, while wash-
out of APO caused more intensive increase of fluorescence than control. The re-
sults are explained by the inhibition of NOXbyAPOwhich results in decrease of
ROS and overproduction of ROSduringwashout utilizing accumulatedNADPH
produced by prior NOX inhibition. ROSwhich changes dynamically in situ, e.g.
hypoxia and reoxygenation, seems to be vital to sustain ICa,L.
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Voltage-gated T-type Ca2þ channel (TTCC), Cav3.1 and Cav3.2, are normally
expressed during cardiac development but are re-expressed in cardiac hypertro-
phy and may contribute to the altered intracellular Ca2þ during this disease.
However, the mechanism of altered Ca2þ signaling in cardiac hypertrophy is
not clearly known. Caveolae containing scaffolding protein caveolin-3 (Cav-
3), provide spatiotemporal regulation of intracellular Ca2þ in cardiomyocytes.
To define the source of signaling Ca2þ involved and basis of dysregulated con-
tractile function in cardiac hypertrophy and to investigate the role of caveolae
and TTCC in the regulation of Ca2þ signaling, we used a transthorasic aortic
constriction (TAC) induced mouse model of cardiac hypertrophy. Western
blot analysis revealed re-expression of Cav3.1 and Cav3.2 proteins and signif-
icant increase in expression of Cav-3 in adult ventricle from TAC mice but not
from sham treated mice. Electron microscopy analysis demonstrated significant
increase in the number of caveolae and co-localization of Cav3.2 and Cav-3 in
the ventricular myocytes in the TAC hearts. Co-immunoprecipitation analysis
using anti-Cav-3 antibody revealed that re-expressed Cav3.2 co-IPs with Cav-3
in the TAC hearts, but not in sham hearts. GST pull-down analysis using Cav-3
fusion proteins confirmed that Cav-3 directly associates with Cav3.2 channels.
Whole cell patch clamp analysis in HEK293 cells co-expressed with either
CaV3.2 and wild-type Cav-3 or GFP revealed that co-expression of Cav3.2 þ
Cav-3 significantly decreased the peak ICav3.2 (12 5 3 pA/pF, n=11) com-
pared to Cav3.2þGFP (31 5 4 pA/pF, n=11). Whereas co-expression of
Cav-3 had no effect on the ICav3.1. Cav-3 coexpression did affect the voltage
dependent activation or inactivation of ICav3.2. We conclude that Cav-3 associ-
ates with Cav3.2 channels and regulates its function. Increased Cav-3 expres-
sion may play a crucial role in regulation of Ca2þ signaling during hypertrophic
cardiomyopathy.
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The Ca2þ/calmodulin-dependent protein kinase II (CaMKII) phosphorylates
the Kv4.2/Kv4.3 channel and slows down the cardiac Ito current inactivation.
Thereby the regulation of the Ito channel by CaMKII regulates the duration
of the plateau phase of the action potential and the calcium entry into the
cell. The expression of the CaMKII is very high in the heart, therefore the com-
partmentalization is essential to get its specificity. We hypothesized that the Ito
channel forming proteins Kv4.2/Kv4.3 and CaMKII colocalized within the
cholesterol enriched membrane microdomains named lipid rafts. We used
freshly isolated ventricular myocytes isolated from Sprague-Dawley rats. Ito
current recordings were made by the Patch-Clamp technique. Membrane rafts
were isolated by centrifugation in a discontinuous sucrose density gradient.
Protein-protein interactions were determined by co-immunoprecipitation. The
different proteins were visualized by western blot. The Kv4.2, Kv4.3 and CaM-
KII proteins were localized by immunohistochemistry. Pach-Clamp recordings
show that cholesterol depleting agent metil-b-cyclodextrine, eliminates the
CaMKII effect on Ito. This result indicates that the Ito channel and CaMKII
are localized in lipid rafts. In contrast, when we incubate the cells with colchi-
cine, a microtubule disrupting agent that internalizes caveolae, the CaMKII
effect on Ito is not modified. Separation in density gradients show that theCaMKII is localized in lipid rafts as well as the Kv4.2/Kv4.3 channels.
In the co-immunoprecipitation experiments we observe that CaMKII is
pulled down with Kv4.2/Kv4.3, but not with caveolin. Immunocitochemistry
experiments show that there are two populations of Kv4.2/Kv4.3 channels.
The CaMKII regulates the population localized in non-caveolar lipid rafts,
whereas a different population is localized in caveolae and is not regulated
by CaMKII. Supported by a MEC grant (SAF2007-61159).
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Therapeutic strategies such as using channel blockers and reducing culture tem-
perature have been used to rescue some long-QT associated voltage-gated po-
tassium Kv trafficking defective mutant channels. A hyperpolarization-acti-
vated cyclic nucleotide-gated HCN4 pacemaker channel mutant (D553N) has
been recently found in a patient associated with cardiac arrhythmias including
long-QT. D553N showed the defective trafficking to the cell surface, leading to
little ionic current expression (loss-of-function). We show in this report that en-
hanced tyrosine phosphorylation mediated by Src, Fyn, and Yes kinases was
able to restore the surface expression of D553N for normal current expression.
Src or Yes, but not Fyn, significantly increased the current density and surface
expression of D553N. Fyn accelerated the activation kinetics of the rescued
D553N. Co-expression of D553N with Yes exhibited the slowest activation ki-
netics of D553N. Src, Fyn, and Yes significantly enhanced the tyrosine phos-
phorylation of D553N. A combination of Src, Fyn, and Yes rescued the current
expression and the gating of D553N comparable to those of wild-type HCN4.
In conclusion, we demonstrate a novel mechanism using three endogenous Src
kinases to rescue a trafficking defective HCN4 mutant channel (D553N) by
enhancing the tyrosine phosphorylation of the mutant channel protein.
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The expression and activity of different channel types mark and regulate spe-
cific stages of cancer progression, from cell proliferation and apoptosis, to in-
vasiveness, angiogenesis and metastatic spread. As is being increasingly recog-
nized, some of these roles can be attributed to signaling mechanisms
independent of ion flow. Evidence is particularly extensive for Kþ channels.
For example, intracellular signaling cascades can be triggered when ion chan-
nels form protein complexes with other membrane proteins such as integrins or
growth factor receptors.
Work in our lab has established that hERG1 Kþ channels are often aberrantly
expressed in primary human cancers and exert pleiotropic effects in cancer
cells, in turn regulating cell proliferation, cell motility and invasiveness or stim-
ulating the process of neo-angiogenesis. hERG1 can induce such diverse effects
since it triggers and modulates intracellular signaling cascades. This role de-
pends on the formation, on the plasma membrane of tumor cells, of macromo-
lecular complexes with integrin receptors, in particular with the b1 subunit. Re-
cent FRET experiments have clearly shown that hERG1 and b1 directly
interact, the intermolecular distance between the two proteins being around 4
nm. Moreover, the hERG1 protein inside the complex could function differ-
ently from its classical role in excitable cells, i.e. independently of ion flux,
but through a conformational coupling with the partner protein(s). On the
whole, data gathered so far allow us to propose a novel antineoplastic thera-
peutical approach, based on the targeting and unlocking of the b1 /hERG1 com-
plex, in order to impair the hERG1-mediated signaling in cancer cells.
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We investigated signalling cascades and coupling to M channel modulation of
two types of Gq/11-coupled receptors in rat nociceptive DRG neurons: bradyki-
nin (BK) B2 and substance P (SP) neurokinin (NK) receptors. In patch clamp
experiments, BK induced a rapid and reversible inhibition of M current which
was prevented by blocking phospholipase C or buffering cytosolic Ca2þ. In
contrast, SP (1uM) failed to inhibit M current in 35 neurons tested, instead pro-
ducing slow augmentation (1625 18%) in 19/35 predominantly TRPV1-pos-
itive neurons. The augmentation was not reversible by washout but was
